{"id":"https://openalex.org/W2064874512","doi":"https://doi.org/10.1097/00004714-199804000-00004","title":"A Controlled Trial of Ondansetron, a 5-HT3 Antagonist, in Benzodiazepine Discontinuation","display_name":"A Controlled Trial of Ondansetron, a 5-HT3 Antagonist, in Benzodiazepine Discontinuation","alternate_titles":[],"publication_year":1998,"publication_date":"1998-04-01","ids":{"openalex":"https://openalex.org/W2064874512","doi":"https://doi.org/10.1097/00004714-199804000-00004","mag":"2064874512","pmid":"https://pubmed.ncbi.nlm.nih.gov/9555597"},"language":"en","primary_location":{"id":"doi:10.1097/00004714-199804000-00004","doi":"https://doi.org/10.1097/00004714-199804000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199804000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2064874512"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109204727","display_name":"Myroslava K. Romach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2801816099","display_name":"Women's College Hospital","ror":"https://ror.org/03cw63y62","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801816099"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Myroslava K. Romach","raw_affiliation_strings":["Department of Pharmacology, University of Toronto, Ontario, Canada","Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada","Myroslava K. Romach, MSc, MD, Women's College Hospital, Department of Psychiatry, 76 Grenville St., Toronta, Ontario, Canada M5S 1B2"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Myroslava K. Romach, MSc, MD, Women's College Hospital, Department of Psychiatry, 76 Grenville St., Toronta, Ontario, Canada M5S 1B2","institution_ids":["https://openalex.org/I2801816099"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103489619","display_name":"Howard L. Kaplan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Howard L. Kaplan","raw_affiliation_strings":["Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111816048","display_name":"Usoa E. Busto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Usoa E. Busto","raw_affiliation_strings":["Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072951311","display_name":"Gail R. Somer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gail Somer","raw_affiliation_strings":["Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013791504","display_name":"Edward M. Sellers","orcid":"https://orcid.org/0000-0002-0669-2373","observed_orcids":["https://orcid.org/0000-0002-0669-2373"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Edward M. Sellers","raw_affiliation_strings":["Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacology, Medicine and Psychiatry and Faculty of Pharmacy, University of Toronto and Addiction Research Foundation, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5109204727"],"corresponding_institution_ids":["https://openalex.org/I185261750","https://openalex.org/I2801816099"],"apc_list":null,"apc_paid":null,"fwci":1.7012,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":{"value":0.81837607,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"18","issue":"2","first_page":"121","last_page":"131"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.5619999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.5619999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.21439999341964722,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.02810000069439411,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ondansetron","display_name":"ondansetron","score":1.0},{"id":"https://openalex.org/keywords/5-ht3-receptor-antagonists","display_name":"5-HT3 receptor antagonists","score":0.9559999704360962},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.9169999957084656},{"id":"https://openalex.org/keywords/benzodiazepine-discontinuation","display_name":"benzodiazepine discontinuation","score":0.9589999914169312},{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":0.8209999799728394},{"id":"https://openalex.org/keywords/lorazepam","display_name":"lorazepam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/adjunctive-pharmacotherapy","display_name":"adjunctive pharmacotherapy","score":0.7039999961853027},{"id":"https://openalex.org/keywords/tapering","display_name":"tapering","score":0.5820000171661377},{"id":"https://openalex.org/keywords/serotonin","display_name":"serotonin","score":0.5509999990463257},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.6129999756813049},{"id":"https://openalex.org/keywords/placebo-response","display_name":"placebo response","score":0.7289999723434448}],"concepts":[{"id":"https://openalex.org/C2777170512","wikidata":"https://www.wikidata.org/wiki/Q410011","display_name":"Ondansetron","level":3,"score":0.9830164909362793},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.9121900796890259},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.8010337352752686},{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.7646307945251465},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6281031370162964},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6086013317108154},{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.5629993081092834},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5447337627410889},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.4448170065879822},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.4140545427799225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2724674940109253},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.20786452293395996},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.20180076360702515},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008140","descriptor_name":"Lorazepam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017294","descriptor_name":"Ondansetron","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017294","descriptor_name":"Ondansetron","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004714-199804000-00004","doi":"https://doi.org/10.1097/00004714-199804000-00004","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004714-199804000-00004","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:9555597","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9555597","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W61697213","https://openalex.org/W103965615","https://openalex.org/W178114128","https://openalex.org/W192226528","https://openalex.org/W199732434","https://openalex.org/W1640209568","https://openalex.org/W1916496493","https://openalex.org/W1981558694","https://openalex.org/W1982344701","https://openalex.org/W1990397462","https://openalex.org/W1990666576","https://openalex.org/W1996454411","https://openalex.org/W1998935547","https://openalex.org/W2002389556","https://openalex.org/W2003125564","https://openalex.org/W2005826815","https://openalex.org/W2009821818","https://openalex.org/W2015200106","https://openalex.org/W2019012629","https://openalex.org/W2028560297","https://openalex.org/W2035581455","https://openalex.org/W2035912276","https://openalex.org/W2036196583","https://openalex.org/W2058737495","https://openalex.org/W2059354993","https://openalex.org/W2063369539","https://openalex.org/W2063980879","https://openalex.org/W2064644850","https://openalex.org/W2071220073","https://openalex.org/W2076544556","https://openalex.org/W2092582269","https://openalex.org/W2115610172","https://openalex.org/W2131823335","https://openalex.org/W2136646847","https://openalex.org/W2137880719","https://openalex.org/W2150602253","https://openalex.org/W2151756295","https://openalex.org/W2168595696","https://openalex.org/W2407330044","https://openalex.org/W2614027816","https://openalex.org/W4238079920"],"related_works":["https://openalex.org/W2993253806","https://openalex.org/W2262893338","https://openalex.org/W2063369539","https://openalex.org/W2064644850","https://openalex.org/W2091919635","https://openalex.org/W2719848919","https://openalex.org/W2004415528","https://openalex.org/W2059204867","https://openalex.org/W2010590385","https://openalex.org/W2108608442"],"abstract_inverted_index":{"Serotonin":[0],"is":[1],"implicated":[2],"in":[3,10,52,57,143,200],"the":[4,11,44,53,112,125,144,150],"etiology":[5],"of":[6,14,38,46,55,124,129,133,135,162,167,176,185],"anxiety":[7,34],"disorders":[8],"and":[9,29,76,97,117,152],"anxiolytic":[12,27],"actions":[13],"benzodiazepines.":[15],"Preclinical":[16],"studies":[17],"with":[18],"5-HT3":[19],"receptor":[20],"antagonists,":[21],"including":[22],"ondansetron,":[23],"show":[24],"they":[25,87,189],"have":[26,173],"properties":[28],"that":[30,188],"ondansetron":[31,47,90,151,178,199],"suppresses":[32],"withdrawal":[33,163],"after":[35],"abrupt":[36],"discontinuation":[37,54,82],"chronic":[39],"benzodiazepine":[40,101,136,202],"treatment.":[41,119],"We":[42],"evaluated":[43],"efficacy":[45],"as":[48],"an":[49,177],"adjunctive":[50],"medication":[51],"benzodiazepines":[56],"long-term":[58],"users.":[59],"One":[60],"hundred":[61],"eight":[62],"patients":[63,113,126,186],"who":[64,114],"had":[65,115,156],"used":[66],"alprazolam":[67],"or":[68,95,165],"lorazepam":[69],"regularly":[70],"for":[71,149],">":[72],"3":[73],"months":[74],"entered,":[75],"97":[77],"completed":[78,118],"a":[79,103],"randomized":[80],"double-blind":[81],"treatment":[83,145],"program":[84],"during":[85],"which":[86],"received":[88],"either":[89],"2":[91],"mg":[92],"twice":[93],"daily":[94,137],"placebo":[96,153,170],"flexibly":[98],"tapered":[99,201],"their":[100],"over":[102],"6-week":[104],"period.":[105],"There":[106],"were":[107,195],"no":[108,157],"significant":[109,158],"differences":[110],"between":[111],"entered":[116],"Three":[120],"weeks":[121],"postmedication,":[122],"63%":[123],"discontinued":[127],"use":[128],"benzodiazepine.":[130,192],"The":[131],"percentage":[132],"reduction":[134],"dosage":[138],"at":[139],"all":[140],"time":[141],"points":[142],"trial":[146],"was":[147],"similar":[148],"groups.":[154],"Ondansetron":[155],"effects":[159],"on":[160],"severity":[161],"symptoms":[164],"levels":[166],"anxiety.":[168],"High":[169],"response":[171],"may":[172],"prevented":[174],"detection":[175],"effect.":[179],"At":[180],"1":[181],"year":[182],"follow-up,":[183],"68%":[184],"reported":[187],"stopped":[190],"using":[191],"Patient":[193],"characteristics":[194],"more":[196],"important":[197],"than":[198],"discontinuation.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2064874512","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
